- Home
- CNC vs ICLR Comparison
CNC vs ICLR Comparison
Compare CNC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNC
- ICLR
- Stock Information
- Founded
- CNC 1984
- ICLR 1990
- Country
- CNC United States
- ICLR Ireland
- Employees
- CNC N/A
- ICLR N/A
- Industry
- CNC Medical Specialities
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CNC Health Care
- ICLR Health Care
- Exchange
- CNC Nasdaq
- ICLR Nasdaq
- Market Cap
- CNC 14.3B
- ICLR 13.7B
- IPO Year
- CNC 2001
- ICLR 1998
- Fundamental
- Price
- CNC $33.26
- ICLR $175.00
- Analyst Decision
- CNC Hold
- ICLR Buy
- Analyst Count
- CNC 16
- ICLR 15
- Target Price
- CNC $38.33
- ICLR $209.93
- AVG Volume (30 Days)
- CNC 14.8M
- ICLR 1.0M
- Earning Date
- CNC 10-24-2025
- ICLR 10-22-2025
- Dividend Yield
- CNC N/A
- ICLR N/A
- EPS Growth
- CNC N/A
- ICLR 13.11
- EPS
- CNC 4.07
- ICLR 9.73
- Revenue
- CNC $159,560,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- CNC $30.26
- ICLR N/A
- Revenue Next Year
- CNC N/A
- ICLR $1.73
- P/E Ratio
- CNC $8.17
- ICLR $17.99
- Revenue Growth
- CNC 10.57
- ICLR N/A
- 52 Week Low
- CNC $25.08
- ICLR $125.10
- 52 Week High
- CNC $77.29
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- CNC 64.21
- ICLR 53.09
- Support Level
- CNC $28.24
- ICLR $164.00
- Resistance Level
- CNC $36.14
- ICLR $180.95
- Average True Range (ATR)
- CNC 1.10
- ICLR 6.38
- MACD
- CNC 0.72
- ICLR -0.99
- Stochastic Oscillator
- CNC 63.54
- ICLR 64.59
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.